Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tuğba Önal-Süzek has a total of 128 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Photograph-Based Skeletal Malocclusion Screening with Geometric Machine Learning: External Validation Across Turkish and Non-European Cohorts

    by Aslı Eker Davut, Mehmet Cihan Sakman, Ahmet Yağcı, Berrak Çakmak, Emmanuel Jr Dumu, Yunus Emre Uçaker, Cenk Ahmet Akcan, Özgür Kılıç, Tuğba Önal-Süzek, Banu Kılıç

    A photograph-based screening classifier for skeletal malocclusion maps 100 engineered geometric feature vectors, derived from a side-profile smartphone photograph, to orthodontic class labels, enabling non-invasive triage without radiographic imaging. This study reports external validation across two independent cohorts that contributed no cases to training. Two binary tasks were evaluated; Class III against non-Class III, and Class I against Class II; each with its own development set and model, applied without modification at the default threshold. One external cohort was Turkish, drawn from an institution not represented in the development set; the other was a non-European cohort from a Belgian private orthodontic clinic. Sensitivity, specificity and the area under the receiver operating characteristic curve (AUC) were pre-specified as primary outcome measures, since none depends on outcome prevalence. In the Class III task, sensitivity was similar across all three evaluation sets (0.801, 0.836, 0.848; all adjusted p>0.7), while specificity fell from 0.766 in the Turkish external cohort to 0.697 in the non-European cohort. AUC was 0.902 and 0.835 respectively (difference 0.066; p=0.029). In the Class I and Class II task the corresponding values were 0.875 and 0.723 (difference 0.152; p<0.001). A subgroup analysis showed lower sensitivity in children than adults across both cohorts (0.71–0.80 versus 0.89–0.90). AUC was lower in the non-European cohort for all three models in both tasks. The observed performance differences are consistent with a population-specific generalizability effect rather than model-specific failure and support mandatory external validation on target populations before clinical deployment.

  • Open Access

    Integrated Transcriptomic and Structural Prioritization of Sulforaphane Targets in Neurodegeneration: A Multi-Dataset In Silico Study

    by Semra Ugur, Tugba Onal Suzek

    Sulforaphane (SFN), a natural isothiocyanate from cruciferous vegetables, exerts neuroprotective effects through mechanisms extending beyond canonical Nrf2/ARE activation. Here, we developed a multi-dataset computational framework integrating transcriptomic analysis, multi-criteria target prioritization, and structural docking evaluation. R- and S-SFN were docked against 693 prioritized targets using AutoDock Vina, followed by cross-validation, brain expression profiling, and molecular dynamics simulations. Four genes (IGSF9, KCNQ5, KCTD12, and NFIX) were dysregulated across all four datasets. Among 693 targets, 88 showed favorable predicted docking scores (ΔG ≤ −4.0 kcal/mol), with 65 (73.9%) exhibiting expression in at least one GTEx brain region. Independent cross-validation showed significant enrichment of prioritized targets in an SFN-responsive Alzheimer’s disease transcriptomic dataset (OR = 1.44, 95% CI: 1.08–1.89, p = 0.0104). Complementary disease gene set enrichment confirmed that 33% of strong hits (29/88) overlap established neurodegeneration gene sets across AD, PD, and ALS — including ACHE,target of FDA-approved anti-AD drugs — with highly significant enrichment across all three disease categories (OR range: 67–127, all p < 0.001). R-SFN showed a modest but statistically detectable preference over S-SFN across the 88 strong hits (Wilcoxon p = 0.0081; paired t-test p = 0.0047). TMEM45A, GRIK2, and FABP3 emerged as putative neurodegeneration-relevant targets. Molecular dynamics simulations supported the structural stability of R-SFN poses for TMEM45A, GRIK2, and FABP3, while MM-GBSA estimated favorable binding energies for GRIK2 (ΔG_bind = −19.78 kcal/mol) and FABP3 (ΔG_bind = −14.49 kcal/mol). These findings generate testable hypotheses regarding previously underexplored molecular targets that may contribute to the neuroprotective actions of SFN.

  • Open Access

    Propofol orchestrates long non-coding RNAs in MCF7 cells, unraveling new avenues for breast cancer intervention

    by Cigir Biray Avci, Tuba Gokdogan Edgunlu, Tugba Suzek, Neslihan Pinar Ozates, Bakiye Goker Bagca, Aysegul Demirtas Bilgic, Cilem Ozdemir, Bakiye Ugur


  • Open Access

    Smart Wristband Monitoring: A Caregiver-Oriented Mobile Application for Tracking Cognitive Decline in Mild Cognitive Impairment Patients

    by Barış Ceyhan, Semai Bek, Tuğba Önal-Süzek

    Mild Cognitive Impairment (MCI) is the transitional phase between the typical expected memory problems related to age and the more serious decline of dementia. Therefore, monitoring progress from MCI to dementia is critical to slowing down this cognitive deterioration. Research shows that proper nutrition, routine brain, and physical exercise accompanied by proper care slow down the disease significantly. However, most of the patients do not perform these exercises regularly and their vital health data is not monitored properly, leaving patients most of the time with only basic care. In this study, for the first time to our knowledge, we aimed to develop a mobile application that will enable caregivers to continuously monitor the vital health, medication, activity, and location of the patients with MCI with a smart wristband while enabling them caregivers to track the progress of the disease by a machine learning model that tracks MMSE of the patient using speech. Based on our research so far, this caregiver-oriented approach with the ability to track progress of the disease using the convenience of a mobile application is a unique attempt in the field. Patient profile along with collected data is correlated with tracked MMSE scores of the patients to come up with recommendations and findings about the patients. Caregivers are relieved to be notified about critical health data thresholds, progress, and condition of their patients.


  • Open Access

    The association of ZIC5 gene rs965623242 polymorphism with neural tube defects

    by Ebru Önalan, Yasemin Aşkın, Tugce Kaymaz, Mehmet Saraç, Ahmet Kazez, Tuğba Süzek, Vahit Konar

    Objective: This study aims to evaluate the effects of the rs965623242 reference single nucleotide polymorphism (SNP) on the ZIC5 gene in patients with neural tube defect (NTD). Patients and Methods: One hundred sixty-eight controls and one hundred sixty-eight NTD patients were included in the study. Deoxyribonucleic acid (DNA) isolation from peripheral blood samples was carried out for all participants. rs965623242 polymorphic region was amplified by polymerase chain reaction (PCR) and then sequenced. Results: In the 5’ untranslated region (UTR) of the first exon, guanine (G) to adenine (A) base change was detected in the 38th base of NM_033132.5. G to A base change was determined as GG genotype in 117 (69.6%), AG genotype in 30 (17.86%), and AA genotype in 21 (12.5%) patients. In the control group, GG genotype in 107 (63.7%), AG genotype in 23 (13.7%) and AA genotype in 38 (22.7%) were observed. The statistically significant difference was observed between the NTD and the control groups in ZIC5 genotypes or allele frequencies [p=0.044, odds ratio (OR)=0.49 (0.27-0.88) and p=0.021, OR=0.65 (0.46-0.93), respectively]. Conclusion: ZIC5 rs965623242 polymorphism may have a protective role in the NTD development in the Eastern Anatolian population, in Turkey. Although, these findings demonstrate that the rs965623242 polymorphism is associated with NTD, we do not clarify how its expression is affected during the embryonic period and ongoing processes. We will need advanced ongoing genetic and clinical studies to obtain more detail.


  • Open Access

    Machine Learning-Based Prediction Models for Cognitive Decline Progression: A Comparative Study in Multilingual Settings Using Speech Analysis

    by B. Ceyhan, S. Bek, T. Onal-Suzek

    Mild cognitive impairment (MCI) is a condition commonly associated with dementia. Therefore, early prediction of progression from MCI to dementia is essential for preventing or alleviating cognitive decline. Given that dementia affects cognitive functions like language and speech, detecting disease progression through speech analysis can provide a cost-effective solution for patients and caregivers. In our study, we examined spontaneous speech (SS) and written Mini Mental Status Examination (MMSE) scores from a 60-patient dataset obtained from the Mugla University Dementia Outpatient Clinic (MUDC) and a 153-patient dataset from the Alzheimer’s Dementia Recognition through Spontaneous Speech (ADRess) challenge. Our study, for the first time, analyzed the impact of audio features extracted from SS in distinguishing between different degrees of cognitive impairment using both an Indo-European language and a Turkic language, which exhibit distinct word order, agglutination, noun cases, and grammatical markers. When each machine learning model was tested on its respective trained language, we attained a 95% accuracy using the random forest classifier on the ADRess dataset and a 94% accuracy on the MUDC dataset employing the multilayer perceptron (MLP) neural network algorithm. In our second experiment, we evaluated the effectiveness of each language-specific machine learning model on the dataset of the other language. We achieved accuracies of 72% for English and 76% for Turkish, respectively. These findings underscore the cross-language potential of audio features for automated tracking of cognitive impairment progression in MCI patients, offering a convenient and cost-effective option for clinicians or patients.


  • Open Access

    TCGAnalyzeR: An Online Pan-Cancer Tool for Integrative Visualization of Molecular and Clinical Data of Cancer Patients for Cohort and Associated Gene Discovery

    by Talip Zengin, Başak Abak Masud, Tuğba Önal-Süzek

    For humans, the parallel processing capability of visual recognition allows for faster comprehension of complex scenes and patterns. This is essential, especially for clinicians interpreting big data for whom the visualization tools play an even more vital role in transforming raw big data into clinical decision making by managing the inherent complexity and monitoring patterns interactively in real time. The Cancer Genome Atlas (TCGA) database’s size and data variety challenge the effective utilization of this valuable resource by clinicians and biologists. We re-analyzed the five molecular data types, i.e., mutation, transcriptome profile, copy number variation, miRNA, and methylation data, of ~11,000 cancer patients with all 33 cancer types and integrated the existing TCGA patient cohorts from the literature into a free and efficient web application: TCGAnalyzeR. TCGAnalyzeR provides an integrative visualization of pre-analyzed TCGA data with several novel modules: (i) simple nucleotide variations with driver prediction; (ii) recurrent copy number alterations; (iii) differential expression in tumor versus normal, with pathway and the survival analysis; (iv) TCGA clinical data including metastasis and survival analysis; (v) external subcohorts from the literature, curatedTCGAData, and BiocOncoTK R packages; (vi) internal patient clusters determined using an iClusterPlus R package or signature-based expression analysis of five molecular data types. TCGAnalyzeR integrated the multi-omics, pan-cancer TCGA with ~120 subcohorts from the literature along with clipboard panels, thus allowing users to create their own subcohorts, compare against existing external subcohorts (MSI, Immune, PAM50, Triple Negative, IDH1, miRNA, metastasis, etc.) along with our internal patient clusters, and visualize cohort-centric or gene-centric results interactively using TCGAnalyzeR.


  • Open Access

    CompCorona: A web application for comparative transcriptome analyses ofcoronaviruses reveals SARS-CoV-2-specific host response

    by Rana Sali̇hOğlu, Fati̇h Saraçoğlu, Mustafa Si̇bAi̇, Tali̇p Zengi̇n, Başak Abak Masud, Onur Karasoy, Tuğba Önal Süzek

    Background/aim: Understanding the mechanism of host transcriptomic response to infection by the SARS-CoV-2 virus is crucial, especially for patients suffering from long-term effects of COVID-19, such as long COVID or pericarditis inflammation, potentially linked to side effects of the SARS-CoV-2 spike proteins. We conducted comprehensive transcriptome and enrichment analyses on lung and peripheral blood mononuclear cells (PBMCs) infected with SARS-CoV-2, as well as on SARS-CoV and MERS-CoV, to uncover shared pathways and elucidate their common disease progression and viral replication mechanisms. Materials and methods: We developed CompCorona, the first interactive online tool for visualizing gene response variance among the family Coronaviridae through 2D and 3D principal component analysis (PCA) and exploring systems biology variance using pathway plots. We also made preprocessed datasets of lungs and PBMCs infected by SARS-CoV-2, SARS-CoV, and MERS-CoV publicly available through CompCorona. Results: One remarkable finding from the lung and PBMC datasets for infections by SARS-CoV-2, but not infections by other coronaviruses (CoVs), was the significant downregulation of the angiogenin (ANG) and vascular endothelial growth factor A (VEGFA) genes, both directly involved in epithelial and vascular endothelial cell dysfunction. Suppression of the TNF signaling pathway was also observed in cells infected by SARS-CoV-2, along with simultaneous activation of complement and coagulation cascades and pertussis pathways. The ribosome pathway was found to be universally suppressed across all three viruses. The CompCorona online tool enabled the comparative analysis of 9 preprocessed host transcriptome datasets of cells infected by CoVs, revealing the specific host response differences in cases of SARS-CoV-2 infection. This included identifying markers of epithelial dysfunction via interactive 2D and 3D PCA, Venn diagrams, and pathway plots. Conclusion: Our findings suggest that infection by SARS-CoV-2 might induce pulmonary epithelial dysfunction, a phenomenon not observed in cells infected by other CoVs. The publicly available CompCorona tool, along with the preprocessed datasets of cells infected by various CoVs, constitutes a valuable resource for further research into CoV-associated syndromes.


  • Open Access

    A family-centered orthodontic screening approach using a machine learning-based mobile application

    by Banu Kılıç, Ahmed Hassan İbRahim, Selahattin Aksoy, Mehmet Cihan Sakman, Gül Sude Demircan, Tuğba Önal-Süzek


  • Open Access

    A PERSONALIZED ONCOLOGY MOBILE APPLICATION INTEGRATING CLINICAL AND GENOMIC FEATURES TO PREDICT THE RISK STRATIFICATION OF LUNG CANCER PATIENTS VIA MACHINE LEARNING

    by Mehmet Cihan Sakman, Talip Zengi̇n, Deniz Kurşun, Tuğba SÜZEK

    Predicting lung adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC) risk status is a crucial step in precision oncology. In current clinical practice, clinicians, and patients are informed about the patient's risk group only with cancer staging. Several machine learning approaches for stratifying LUAD and LUSC patients have recently been described, however, there has yet to be a study that compares the integrated modeling of clinical and genetic data from these two lung cancer types. In our work, we used a prognostic prediction model based on clinical and somatically altered gene features from 1026 patients to assess the relevance of features based on their impact on risk classification. By integrating the clinical features and somatically mutated genes of patients, we achieved the highest accuracy; 93% for LUAD and 89% for LUSC, respectively. Our second finding is that new prognostic genes such as KEAP1 for LUAD and CSMD3 for LUSC and new clinical factors such as the site of resection are significantly associated with the risk stratification and can be integrated into clinical decision making. We validated the most important features found on an independent RNAseq dataset from NCBI GEO with survival information (GSE81089) and integrated our model into a user-friendly mobile application. Using this machine learning model and mobile application, clinicians and patients can assess the survival risk of their patients using each patient’s own clinical and molecular feature set.